Identification des biomarqueurs pour l’individualisation des traitements dans les cancers colorectaux
Le cancer colorectal (CCR) est un problème majeur de santé publique. Les nouvelles stratégies thérapeutiques incluant les anticorps anti-EGFR ou anti-VEGF en association avec les chimiothérapies ont amélioré la survie des patients présentant un CCR métastatique. Nous avons évalué le rôle de nouveau...
Main Author: | Dobi, Erion |
---|---|
Other Authors: | Besançon |
Language: | fr |
Published: |
2012
|
Subjects: | |
Online Access: | http://www.theses.fr/2012BESA3011 |
Similar Items
-
Serum and tissue angiogenin in patients with endometrial hyperplasia
by: Mohamed Abelsalam Mohamed, et al.
Published: (2010-10-01) -
Aberrant expression of interleukin-23-regulated miRNAs in T cells from patients with ankylosing spondylitis
by: Ning-Sheng Lai, et al.
Published: (2018-11-01) -
The association between serum angiogenin and osteopontin levels and coronary collateral circulation in patients with chronic total occlusion
by: Kadri Murat Gürses, et al.
Published: (2019-08-01) -
Angiogenin and osteopontin and coronary collateral circulation
by: Joob Beuy, et al.
Published: (2019-09-01) -
The Anti-Inflammatory Effects of Angiogenin in an Endotoxin Induced Uveitis in Rats
by: Jihae Park, et al.
Published: (2020-01-01)